legislation

Anavex Life Sciences Corporation

wait

Seems crazy to me to unjust approvals that are going on while we wait on legitimate results!!!

But why wait 3 years with that when Anavex 50mg dose is likely better! !

So, if one waits months for an answer and then has to resubmit to another journal it can hold things up.

This is a shitshow till data is presented.

loss

but  losses  and  disappointment  with  Missling.

$AVXL Took my $250 loss and Got out guys too much noise not enough action.

but was faked by the move and held them to expiration and had to book a loss of $19,000.

shareholder

The krout has proven to be an a hole toward shareholders.

Missling is a greedy pig, doesnt see the bad he does by delaying intentionally, not only to shareholders,

i am telling for years that we need to fire that shitty guy just here to full his pockets without any consideration for his shareholders.

.this guy doesnt respect his shareholders and he must be sue for that.

$AVXL fire Missling, he has been here 9 years and done nothing to drive shareholder value other than BS hype

$AVXL why does the company not believe they are beholden to their shareholders?

$AVXL Unfortunately the Investorshub AVXL board has deteriorated to the point that it is basically a board consisting of almost entirely FUD with almost more bashers than true shareholders.

Messling is grossly deficient in anticipating the expectations of shareholders and the market.

$AVXL as corporate shareholder, I have sent an email on dec. 21st and a friendly reminder yesterday to IR - no response yet !!

One hand he says he care for shareholder value, on other hand he is purposely not sharing updates.

shareprice

$AVXL missling next time should change a few letters when hiring and SP will improve: from FDA to FBI former employee.

$AVXL Every time Missling speaks, the SP tanks…..amateurish communication, unbelievable.

It&#39;s stupid, it wastes time (and $$$) and it leaves the company vulnerable with a supressed SP.

Based on Rett alone, SP is well under 100$, sorry to bust your ballown,but please try to stay realist and keep a little credibility!

$AVXL The sp is wrong there must be a glitch

$AVXL not that i am happy with the SP overall

$AVXL Until you realize that and admit that the presenter screwed up in rushing the presentation the SP will stay where it’s at

$AVXL wandering when we will cross ANVS SP ;) 
never again!!!!

$AVXL we didnt cross ANVS SP yet, no good haha!

show

Take your money from this shit show and deposit in your bank account.

What an absolute unregulated criminal shit show this market has become.

Missling shows poor judgement and is not suited to be ceo.

SHOWS THE EXTREME WEAKNESS AND  DISTRESS THE STOCK IS UNDER.

but need more time to evaluate and announce a conference call for Monday instead we have a shit show.

Worth the risk with patience and not investing lifestyle or bill money.

But, after cognition tests the trial passed all endpoints!

THEN they said it hadnt passed any trials, well  gee whiz now  met BOTH secondary Endpoints. Newsflash.

Key is we passed all endpoints with statically significant results!

After TLR, Anavex will be the owner of a first-in-class, patented, medically-proven, high-demand asset that merely needs to pass through the technicality of government approval to qualify it for mass marketing.

$BIVI what a difference it can make to have a strong ceo: 
Cuong Do (president &amp; ceo): 
Former President of Samsung Global Strategy Group and former Chief Strategy Officer for Merck 
- 
expect the coming 14 days to be really exciting !!

Right now, my 4 most compelling trading ideas are: $SMMT  $JSPR $EDSA &amp; $AVXL.

confusion side effects are benign and could be further mitigated by taking 2-73 before bedtime instead of early in the morning 
 
2. efficacy - even limited, combined 30 mg &amp; 50 mg data so far better than controversial and approved aduhelm.

On awesome news &amp; massive covering! !

No one can beat algos other then precise news&amp;volume!!!

Great results for Alzheimers drug, Parkinsons,Rett Syndrome, Fragile X &amp; other CNS diseases.

business-result

Anavex&#39;s A2-73 Blarcamesine&#39;s trial results on 2 previously completed adult phase-3 trials were highly successful.

But the company actually has never seen before wonderful results.

If results hold up, the stock will achieve massive gains.

The results were excellent on the 2 completed adult trials, and because the 3rd trial is pediatric and early on the disease, they are expected to perform even better.

Alzheimer&#39;s is the most valuable and most difficult indication and most desired lately..  and only Anavex really has some great results with a great safety record. .

The  sava  results  trounce  you  guys  🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

Sava has potential and the phase 3 results will show the truth.

drug

- Timo grimmer is in the team 
- All endpoints of the clinical trial were reached 
 
I firmly believe that the drug works and that the CEO has done a good job no matter how much he is criticized.

we have a drug, even many drugs, good for so many indications,  to become a giant pharma, we are about to get billions in revenues.

$AVXL The improvements in the drug arm cannot be lucky. .

I&#39;m looking forward to seeing the long term AD data on ANVS and have the feeling it&#39;s going to end up being the best in class AD treatment as well.

Do not listen to any FUD this drug is the real deal.

$AVXL amazing to see the actual benefits to people and their families of this “miracle drug” as they call it

$AVXL Dr. Perry said we have a legendary drug which actually reverses AD and is safe unlike Adulhelm.

trial

$AVXL amazing  avxl  still  in  singke  digits  after  a  supposedly  amazing  “pivotal”  trial  readout  🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

$AVXL The trial met both co-primary and secondary endpoints showing statistically significant reduction of clinical decline as measured by those endpoints.

$AVXL Australia trial data meets the gold standard.

2-73 has orphan designation for Rett which combined with the multiple Rett trials and it very good safety record should make it a great candidate for AA.

This company has yet to fail to meet endpoints on any trial and the thousands of papers on the MOA  eliminates fraud with science, and the company is in great fiscal shape so no shenanigans there.

Cassava Sciences Inc

action

The day to day price action of this limp dick is more painful to watch than slugs breeding.

$SAVA , this daily one way action is depressing.

Zero confidence in management based on both recent actions and historical issues with the FDA. 2.

$SAVA We may get frustrated with volatility, manipulation, and irregular daily price action

price

This is sickening that these crooks can manipulate the price like this. !!!

He invites shorts to destroy stock price.. pathetic!

Some had to drop in price a little first!

new employee mr. cook must be pissed as this is lower price than the shares he got it for.

All.u did was dilute the pps 
..and release to prs to kill the stock price and momentum  
 You did so well..you fxuking scumbag.

I hate the stock price runup leading to an announcement.

data

- 
$AVXL in comparison, boring as hell - whenever Missling talks people fall asleep and holding back data and further readouts without any logical explanation are red flags -

$SAVA 
Pyggie here was bullish a few days ago, folded like a pussy because he can’t read data, and now spews FUD, like a spoiled child, because he’s worried he may have paper-handed a monster.

but offer only the “opinion” that there was “possible data manipulation.”

$SAVA longtime biotech investor and my honest experience when a CEO promises good data and there is a long waiting period = not good.

Sentiment matters in this game, and unfortunately, this company has been drug through the mud for so long that good data might just get overlooked.

$SAVA The ironic and sad thing is that this ticker has been abused and manipulated so badly that even if it triples on upcoming data release it still won&#39;t come close to ATH achieved on much less evidence of safety and efficacy.

The CEO belongs in jail with all this pump and dump stock manipulation and data manipulation

just annoying we all get so worked up and insulting when we, the retail investor, can neither move Remi to release data early or in truth, move the SP by buying or selling a few hundred shares.

$SAVA dumb management causing longs to lose confidence, you dont change the date of data release every few weeks, just give a date when you are certain and stick with that, its that simple

BIIB with a 27% chance of no decline - so bad, how can they even publish data like that.

patient

however, if you are a family member of Alz patient think about how fatiguing emotionally and financially it is to change diapers, have your name forgotten, or even have to take a license away from an otherwise healthy person.

but your day will come when you will pay back way more than the damage you have caused and the lives you have threatened from being treated for a debilitating disease.

$ALZN $ATHA $ORMP $SAVA $SPRC yes then go back to your scam board clown no need to trap others in this scam .. we know what value SAVA brings to their AD patients

Lecanemab approved - IV  infusion..increased infection risk, inconvenient for patients with MD&#39;s fully aware 
of side effects: brain swelling and bleeding. 2.

Eventually, the  
AD patient is unable to perform daily functions.

But the monoclonal antibody treatment also carries risks of brain swelling and bleeding.

$BIIB - lied and tried to push their bad drug Aduhelm on unsuspecting patients (one of which is a family member of mine).

3 deaths in 1900 trial patients.. how many deaths is our FDA going to inflict on millions of folks who are supposed to take this death drugs that also happen to have near-zero efficacy?? SMH

Avxl, not good they didn&#39;t have an agreement in place “plan for approval“ before they started the test fase 2b 500 patients.

$SAVA It&#39;s not only CRUEL for anyone to be prescribing any of these MABs for AD patients, it&#39;s impractical for both patients and the healthcare system in general.

application

$SAVA Words  to  to  ignorant,  never  hype  a  employee  from  fda,  shady  shiat! 🤡🤡🤡😂😂😂

It doesn&#39;t matter if drugs for terminal illnesses, have been approved after 6 months, because there is endless manipulation here, and this waiting game is based on either FDA approval or denial based on corruption at the agency?

This is such crap with the FDA my Father died a year ago from it

$BIIB $SAVA You would need uncommon patience to not be crazy mad at the system for this shenanigan approval process and decision from the FDA.

Idiots with no respect for integrity continues  to run 
wild within the FDA.

$SAVA once again we got fu*ked by the evil BIIB + FDA.

$SAVA THIS is how corrupt our FDA and state medical boards are.

$BIIB $SAVA  
I tell ya why - FDA is corrupt deep in its root, period!

$BIVI Biovie Pharmaceuticals $BIVI passes Zacks Equity Research&#39;s strict &quot;Recent Price Strength screen&quot;, and comes out with glowing colors--and a prediction of further momentum for the stock in near term.

$SAVA the risk/reward is too good to pass up.

Will pass the other stocks percentage soon
💎💎💎📈📈📈

$CDTX FDA decision will be made tomorrow $SAVA, $MDGL &amp; $RETA boys I can easily see this up 200%-300% in my opinion on an approval.

$SAVA 💰Come to papa💰 counterfeiters &amp; Fud will be exposed 🔥🩳🔥

$SAVA to the moon &amp; golden retrievers best in class❤️

And, make no mistake, the result are impressive.

It is the best results that have been seen in AD.

This could be huge in eliminating artificial FUD against the top-line results.

$SAVA Market is moving higher as SAVA is expecting data results.

Anavex is late like the sun comes up and still produces great results.

MOST IMPORTANTLY, THE RESULTS MUST HAVE BEEN GOOD AND PROMISING at each snapshot that leads Remi to use the word &quot;Thrilled&quot; in Dec 6 PR.

Data tells me no safety issues, with a possible large therapeutic window.

Then they dropped the “good” totally “not disappointing” data that Remi was so “Thrilled” about.

This will go beyond parabolic on good data … literally no shares out there unless they offer new ones … $MDGL $VKTX $SLS $SAVA

SAVA data gets analyzed by multiple different labs and shows its cognition improvement in mild AD cases, safe and well-tolerated

$SAVA I love not being able to hold $28 off data that will keep it pinned here until 2024.

but the data to date would predict continued efficacy that will be nigh on impossible to ignore.

$SAVA Institutional buying says data is good!! !

I’ll keep buying until data comes out…

Excited for the next data unveiling….bring it on!

$SAVA “Treatment also eased depression and dementia-related behaviors in patients, two exploratory trial goals, and simufilam was found to be safe and well tolerated.”

This will bring in billions of revenue and it will make the life quality longer for AD patients.

This sub-set of patients improved -4.96 mean points on ADAS-Cog from baseline to month 12.

CURING LEUKEMIA isn&#39;t a fly by night thing with Gamma T Cells and they already have ONE COMPLETE RESPONSE curing someone in Stage 4 nonresponsive to other treatments!

$SAVA this is going to be game changer and first drug to give some relief to AD patients … and will make $BIIB poison AD pills an obsolete

The high number of the patients that went into CMS (which is 80% complete) is reassuring.

but reverses cognitive decline and improves quality of life for the patient AND the FAMILY!

but mostly new hope for all the families and patients with AZ.

Testing still continues, so in my way of thinking the real-world results in patients must be nothing short of excellent.

Goldman Sachs Group, Inc.

scam

Grind The Federal Reserve in the garbage disposal.

$GS Investing in this scam stock is like playing a game of chance with your money.

$GS this garbage will underperform all day and close at 318

target

Bunch of rat bastards with pie in the sky price targets and manipulation

$GS scam cunts , they have the worse price targets t manipulation price action.

trading

↳ Why are you paying to be in a Trading Room?

Goldman Sachs is under capitalized and illegally using client money for trading

$GS huge amounts of risky trading which they sucked at last quarter.

$GS 100% spam, lies, et al, not the first time fake dmj has been used, ignore, report this fraudster ron, he&#39;s no guru, my friends, good health and trading to all.

$GS sucks try banking, trading and investing with SoFi come over to $SOFI big banks suck!

$GS shares down -6% for the worst day in 364 trading days (a day shy of the anniversary). Pulling down other banks ($KBE)

analyst

Goldman Sachs missed analysts’ estimates on both the top and bottom lines, with loan loss provisions coming in higher than expected.

$GS traah pos, fk them corrupt scums fake price analyst

but you can’t be down $3.94B QoQ from last year when you have industry peers with less clout $JPM $BAC both pushing out over $2B in profits for the same quarter. Embarrassing.

$GS  atrocious quarter … these pigs overpay themselves richly no matter what their business is doing … no cost control in the compensation and benefits area … embarrassing fail as compared with rival Morgan Stanley

4th straight quarter of declining profits and these guys are heroes???!

💰Gold could easily pass $12,600 (Us dollars) In the coming years.

$SPY I love how $GS expectd the Feds to do what they say 😂 clowns .

$BTC.X $DKNG $GS $QQQ $SPY 
“The world is saying something” that’s a great quote. Cheers.

$QQQ $SPY $DIA $C $GS the banks are all backed with cash, so in my opinion there are no more problems.

$SPY $QQQ $GS well that was easy for bulls today.

$AABB ok new favorite one $AMC $APE.X $SPY $GS  notice the golden shovel

$SPY no rate hike next week $GS now said, very interesting.

bear

.Ready For A Nice Move $25+++ Lots Of Bear Meat Over There!!! DWAC

$GS I dont see too much more downside, bears are getting greedy, in one week we will be back by $360+

🐻❤😈 your 24x7 active short trader care bear specialist for profits  .

$GS tomorrow another bear victory 🐻🐻🐻🐻🐻🐻

Nice fade  on ER 50/50 bet bears got paid this time!

$GS where all my morning bears at 🐻🐻🐻🐻🐻🐻🐻🐻🐻🐻🐻

A nice bear rally next week and overall strength until gdp and end of month QT.

market

$BTC.X here is the 2 quadrillion deravitives market 😂🔥🔥🔥🔥
enjoy the ride fellas $JPM $GS  🖕🏿

$SOFI Fastest growing and best positioned bank in the market especially when compared to the zombie big banks.

$GS  The bullish bias in the options market suggests a positive outlook for the stock We are seeing the $-0.0366561934685327 -11.55 having heavy activity which expire in 65850 days.

$GS 
Reiterates a Market Outperform 
 
🔼 $ 470 PT 
 
At JMP Securities; sees 46% Upside 
 
#GoldmanSachsGr #AnalystRatings

Housing data is up for weeks, job market and economy is stronger then expected, while no available shares to short.

Stay down good for market sentiment $DIA 

Can’t lose

AMD BEFORE IT&#39;S AFTER CLOSE ON TUESDAY THEY CONTINUE TO GROW AS THEY HAVE CONTINUED TO EAT AWAY AT INTEL&#39;S MARKET SHARE.

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Mar, 6, 2023

Dec, 9, 2022

SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Dec, 11, 2022

Oct, 7, 2022

GS

Goldman Sachs Group, Inc.

-15.26%

$374.40 - $317.28

Mar, 16, 2023

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Mar, 6, 2023

Dec, 9, 2022

Dec, 9, 2022

Dec, 9, 2022

Dec, 9, 2022

Dec, 7, 2022

Dec, 7, 2022

Dec, 3, 2022

Oct, 20, 2022

SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Dec, 11, 2022

Oct, 7, 2022

Oct, 4, 2022

GS

Goldman Sachs Group, Inc.

-15.26%

$374.40 - $317.28

Mar, 16, 2023